首页> 外文期刊>European journal of pain : >Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force - a double-blind randomized crossover control study.
【24h】

Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force - a double-blind randomized crossover control study.

机译:运动后肌肉酸痛的预防性托哌酮可降低等轴测力-一项双盲随机交叉对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The role of tolperisone hydrochloride, a centrally acting muscle relaxant in relieving painful muscle spasm is recently being discussed. The present study hypothesizes that the prophylactic use of tolperisone hydrochloride may effectively relieve post-exercise muscle soreness, based on the spasm theory of exercise pain. Twenty male volunteers, aged 25.2+/-0.82 years (mean+/-SEM) participated in 10 sessions in which they received oral treatment with placebo or the centrally acting muscle relaxant tolperisone hydrochloride (150 mg) three times daily for 8 days, in randomized crossover double-blind design. Time course assessments were made for pressure pain threshold, Likert's pain score (0-5), pain areas, range of abduction, isometric force, and electromyography (EMG) root mean square (RMS) during maximum voluntary isometric force on day 1 and 6, immediately after an eccentric exercise of first dorsal interosseous muscle, and 24 and 48 h after the exercise. Treatment with placebo or tolperisone hydrochloride was initiated immediately after the assessments on the first day baseline assessments. On the sixth day baseline investigations were repeated and then the subjects performed six bouts of standardized intense eccentric exercise of first dorsal interosseous muscle for provocation of post-exercise muscle soreness (PEMS). Perceived intensity of warmth, tiredness, soreness and pain during the exercise bouts were recorded on a 10 cm visual analogue pain scale. VAS scores and pressure pain thresholds did not differ between tolperisone and placebo treatment. All VAS scores increased during the exercise bouts 2, 3, 4, 5 and 6 as compared to bout 1. Increased pain scores and pain areas were reported immediately after, 24 and 48 h after exercise. Pressure pain thresholds were reduced at 24 and 48 h after the exercise in the exercised hand. Range of abduction of the index finger was reduced immediately after the exercise and was still reduced at 24 h as compared to the non-exercised hand. The EMG RMS amplitude was also reduced immediately after the exercise, but was increased at 24 and 48 h. Isometric force was reduced immediately after the exercise as compared to days 1, 6, and the 24 and 48 h post-exercise assessments with a greater reduction following the tolperisone hydrochloride treatment and the reduction was more in tolperisone group as compared to the placebo group. The results suggest, that the prophylactic intake of tolperisone hydrochloride provides no relief to pain in course of post-exercise muscle soreness but results in reduction in isometric force.
机译:最近讨论了盐酸托哌酮(一种中枢作用的肌肉松弛剂)在缓解疼痛性肌肉痉挛中的作用。本研究假设基于运动疼痛的痉挛理论,预防性使用盐酸托哌酮可有效缓解运动后肌肉酸痛。 20名年龄在25.2 +/- 0.82岁(平均+/- SEM)的男性志愿者参加了10个疗程,随机接受安慰剂或中枢性肌肉松弛药盐酸托哌酮(150毫克)的口服治疗,每天8次,共8天。交叉双盲设计。在第1天和第6天进行最大自愿等距测力时,对压力痛阈值,李克特的疼痛评分(0-5),疼痛区域,外展范围,等轴测力和肌电图(EMG)均方根(RMS)进行了时程评估偏心运动后的第一背骨间肌,以及运动后24和48小时。在第一天基线评估后,立即开始使用安慰剂或盐酸托哌酮治疗。在第六天,重复基线研究,然后受试者对第一背骨间肌进行了六次标准的剧烈离心运动,以激发运动后的肌肉酸痛(PEMS)。运动发作期间感觉到的温暖,疲倦,酸痛和疼痛的强度以10厘米的视觉模拟疼痛等级记录。托哌酮和安慰剂治疗之间的VAS评分和压力疼痛阈值无差异。与回合1相比,运动回合2、3、4、5和6中的所有VAS评分均增加。运动后,运动后24小时和48小时,疼痛评分和疼痛区域增加。运动后的24 h和48 h压力疼痛阈值降低。运动后,食指的绑架范围立即缩小,与未锻炼的手相比,在24 h时仍会缩小。运动后,EMG RMS振幅也立即降低,但在24和48 h时增加。与运动后第1、6、24天和运动后48小时的评估相比,运动后立即等距力减小,而盐酸托哌酮治疗后的减小幅度更大,而与安慰剂组相比,托哌酮组的减小幅度更大。结果表明,在运动后肌肉酸痛的过程中,预防性摄入盐酸托哌酮不能减轻疼痛,但会降低等轴测力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号